Diagnostic I-123 scintigraphy to assess potential breast uptake of I-131 before radioiodine therapy in a postpartum woman with thyroid cancer

Clinical Nuclear Medicine

Volumn 29, Issue 8, 2004, Pages 498-501

  Hsiao, Edward ^a   Huynh, Thien ^a   Mansberg, Robert ^a   Bautovich, George ^a   Roach, Paul ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Breast irradiation; I 123 scintigraphy; Thyroid carcinoma

Indexed keywords

BROMOCRIPTINE; IODINE 123; LIOTHYRONINE; RADIOACTIVE IODINE; THYROTROPIN;

ADULT; ARTICLE; BETA RADIATION; BREAST CANCER; BREAST FEEDING; CASE REPORT; FEMALE; HUMAN; LACTATION; PUERPERIUM; RADIATION DOSE; RADIATION EXPOSURE; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; WHOLE BODY SCINTISCANNING;

ADULT; BREAST; BREAST FEEDING; FEMALE; HUMANS; IODINE RADIOISOTOPES; LACTATION; POSTPARTUM PERIOD; THYROID NEOPLASMS;

EID: 3242755060     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000132953.07351.65     Document Type: Article

References (11)

1. Bakheet SM, Powe J, Hammami MM. Unilateral radioiodine breast uptake. Clin Nucl Med. 1998;23:170-171.
2. Bakheet SM, Powe J, Hammami MM. Radioiodine uptake in the chest. J Nucl Med. 1997;38:984-986.
3. Bakheet SM, Hammami MM. Patterns of radioiodine uptake by the lactating breast. Eur J Nucl Med. 1994;21:604-608.
4. Cologne JB, Preston DL. Impact of comparison group on cohort dose response regression: an example using risk estimation in atomic-bomb survivors. Health Physics. 2001;80:491-496.
5. Preston DL, Mattsson A, Holmberg E, et al. Radiation effects on breast cancer risk: a pooled analysis of eight cohorts. Radiat Res. 2002;158: 220-235.
6. Zheng T, Holford TR, Mayne ST, et al. Radiation exposure from diagnostic and therapeutic treatments and risk of breast caner. Eur J Cancer Prev. 2002;11:229-235.
7. Alzahrani AS, Bakheet S, Al Mandil M, et al. 1231 isotope as a diagnostic agent in the follow-up of patients with differentiated thyroid cancer: comparison with post I311 therapy whole body scanning. J Clin Endocrinol Metab. 2001;86:5294-5300.
8. Lees W, Mansberg R, Roberts J, et al. The clinical effects of thyroid stunning after diagnostic whole-body scanning with 185 MBq I311 [comment]. Eur J Nucl Med. 2002;29:1421-1427.
9. Gerard SK, Cavalieri RR. 1-123 diagnostic thyroid tumor whole-body scanning with imaging at 6, 24, and 48 hours. Clin Nucl Med. 2002;27: 1-8.
10. Berman M, Braverman LE, Burke J, et al. 1-123, 1-124, 1-125, 1-126, 1-130, 1-131 and 1-132 as sodium iodide. MIRD report no. 5. J Nucl Med. 1975;16:857-860.
11. Mandel SJ, Shankar LK, Benard F, et al. Superiority of iodine-123 compared with iodine-131 scanning for thyroid remnants in patients with differentiated thyroid cancer. Clin Nucl Med. 2001;26:6-9.